StockNews.AISignal intelligence
LivaNova PLC · NASDAQ · Healthcare
Browse public LIVN signals with their source context and measured market impact. Open any signal for its permanent analysis page.
LivaNova shares rose with market momentum. Goldman Sachs sees growth potential in LivaNova. Analyst initiates Buy rating with a $65 price target. Improved corporate strategy may boost performance. Projected EPS growth of 14% through 2027.
View signal analysis- LivaNova reported earnings of $0.73 per share, beating estimates by 62.22%. - Revenue for the quarter was $294.9 million, exceeding expectations by 6.45%. - Company has topped EPS and revenue estimates four times in the past year. Price Impact Rating: bullish Impact Horizon Rating: short-term Type: Earnings
View signal analysis